New 5-in-1 shot aims to protect kids from deadly meningitis

NCT ID NCT06647407

Ongoing ⭐️ VACCINE ⭐️ Sponsor: Sanofi Pasteur, a Sanofi Company Source: ClinicalTrials.gov ↗

Summary

This study is testing a new vaccine designed to protect against five major types of meningococcal disease (A, B, C, W, Y) in children. It involves 750 healthy infants, toddlers, and children up to 9 years old. The main goals are to see how well the new vaccine triggers a protective immune response and to check its safety compared to currently licensed meningitis vaccines.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Hospital das Clínicas da Universidade Federal de Minas Gerais- Site Number : 0760001

Belo Horizonte, Minas Gerais, 30130-100, Brazil
Investigational Site Number : 2030003

Jindřichův Hradec, 377 01, Czechia
Investigational Site Number : 2030004

Ostrava, 700 30, Czechia
Investigational Site Number : 2030007

Pilsen, 301 00, Czechia
Investigational Site Number : 2030008

Prague, 180 00, Czechia
Investigational Site Number : 2030009

Prague, 180 00, Czechia
Investigational Site Number : 2080002

Hvidovre, 2650, Denmark
Investigational Site Number : 2080003

Odense, 5000, Denmark
Investigational Site Number : 2460001

Helsinki, 00100, Finland
Investigational Site Number : 2460002

Seinäjoki, 60100, Finland
Investigational Site Number : 2460004

Oulu, 90220, Finland
Investigational Site Number : 2460005

Jarvenpaa, 04400, Finland
Investigational Site Number : 2460006

Espoo, 02230, Finland
Investigational Site Number : 2460007

Tampere, 33100, Finland
Investigational Site Number : 2460008

Helsinki, 00290, Finland
Investigational Site Number : 2760003

Wolfsburg, 38448, Germany
Investigational Site Number : 2760004

Schönau am Königssee, 83471, Germany
Investigational Site Number : 2760005

Krefeld, 47799, Germany
Investigational Site Number : 2760006

Hürth, 50354, Germany
Investigational Site Number : 2760007

Hürth, 50354, Germany
Investigational Site Number : 2760008

Herxheim, 76863, Germany
Investigational Site Number : 2760009

Mönchengladbach, 41236, Germany
Investigational Site Number : 3400001

San Pedro Sula, Honduras
Investigational Site Number : 3400002

Tegucigalpa, 11101, Honduras
Investigational Site Number : 3400003

Tegucigalpa, 11101, Honduras
Investigational Site Number : 6160001

Lodz, Lódzkie, 91-347, Poland
Investigational Site Number : 6160002

Warsaw, Masovian Voivodeship, 02-793, Poland
Investigational Site Number : 6160003

Warsaw, Masovian Voivodeship, 02-647, Poland
Investigational Site Number : 6160004

Siemianowice Śląskie, Silesian Voivodeship, 41-103, Poland
Investigational Site Number : 6160005

Trzebnica, Lower Silesian Voivodeship, 55-100, Poland
Investigational Site Number : 6160006

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-090, Poland
Investigational Site Number : 7240004

Madrid, 28938, Spain
Investigational Site Number : 7240007

Seville, Sevilla, 41013, Spain
Investigational Site Number : 7240009

Madrid, 28041, Spain
Investigational Site Number : 8260004

Exeter, Devon, EX2 5DW, United Kingdom
Investigational Site Number : 8260007

London, England, E1 1BB, United Kingdom
Investigational Site Number : 8260009

London, England, SW17 0QT, United Kingdom
Investigational Site Number : 8260010

Southampton, Hampshire, SO16 6YD, United Kingdom
Private Practice - Dr. Nelson Rosário- Site Number : 0760004

Curitiba, Paraná, 80810-100, Brazil

Conditions

Explore the condition pages connected to this study.

HEALTHY VOLUNTEERS MENINGOCOCCAL IMMUNIZATION